{
    "organizations": [],
    "uuid": "c2ba61b2fdc27b609b85a2339aebc967c455bb99",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-basilea-pharmaceutica-partner-avir/brief-basilea-pharmaceutica-partner-avir-pharma-launches-basileas-ceftobiprole-in-canada-idUSFWN1RL04L",
    "ord_in_thread": 0,
    "title": "BRIEF-Basilea Pharmaceutica: Partner Avir Pharma Launches Basilea's Ceftobiprole In Canada",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 9 (Reuters) - Basilea Pharmaceutica AG:\n* ITS PARTNER AVIR PHARMA INC HAS LAUNCHED BASILEAâ€™S HOSPITAL ANTIBIOTIC ZEVTERA (CEFTOBIPROLE) IN CANADA Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-04-09T13:24:00.000+03:00",
    "crawled": "2018-04-10T13:01:17.012+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "basilea",
        "pharmaceutica",
        "ag",
        "partner",
        "avir",
        "pharma",
        "inc",
        "launched",
        "basilea",
        "hospital",
        "antibiotic",
        "zevtera",
        "ceftobiprole",
        "canada",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}